Anne Drumond Villela

2-(Quinolin-4-yloxy)acetamides Are Active against Drug-Susceptible and Drug-Resistant <i>Mycobacterium tuberculosis</i> Strains

Kenia Pissinate, Anne Drumond Villela, Valnês S. Rodrigues-Junior et al. · ACS Medicinal Chemistry Letters · 2016 · 50 citations · Full text

Lead Compounds, Antimicrobial Chemotherapy, Pharmaceutical Chemistry +19

New insights into the SAR and drug combination synergy of 2-(quinolin-4-yloxy)acetamides against Mycobacterium tuberculosis

Bruno Couto Giacobbo, Kenia Pissinate, Valnês S. Rodrigues-Junior et al. · European Journal of Medicinal Chemistry · 2016 · 43 citations · Full text

Drug Combination Synergy, Pulmonary Tuberculosis, Allergy +8

A Small Multidrug Resistance-like Transporter Involved in the Arabinosylation of Arabinogalactan and Lipoarabinomannan in Mycobacteria

Gerald Larrouy‐Maumus, Henrieta Škovierová, Rabeb Dhouib et al. · Journal of Biological Chemistry · 2012 · 29 citations · Full text

1H-Benzo[d]imidazoles and 3,4-dihydroquinazolin-4-ones: Design, synthesis and antitubercular activity

Fernanda Souza Macchi, Kenia Pissinate, Anne Drumond Villela et al. · European Journal of Medicinal Chemistry · 2018 · 28 citations

Medicinal Chemistry, Antitubercular Activity, Heterocyclic +5

Mefloquine and its oxazolidine derivative compound are active against drug-resistant Mycobacterium tuberculosis strains and in a murine model of tuberculosis infection

Valnês S. Rodrigues-Junior, Anne Drumond Villela, Raoni S. B. Gonçalves et al. · International Journal of Antimicrobial Agents · 2016 · 27 citations

Pulmonary Tuberculosis, Health Sciences, Medicine +12